No black box warning on record for Palynziq

As of the latest FDA labeling reviewed, Palynziq (PEGVALIASE-PQPZ) does not carry a black box warning. Standard warnings and precautions still apply — see the full Palynziq medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions, Other than Anaphylaxis : Management should be based on the severity of the reaction, recurrence, and clinical judgement. ( 5.3 ) Injection Site Infections : Serious injection site infections, including abscess, cellulitis, necrosis, and ulcer have been reported. Instruct patients to contact their healthcare provider if signs or symptoms of an

No black box warning on record for Palynziq

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions, Other than Anaphylaxis : Management should be based on the severity of the reaction, recurrence, and clinical judgement. ( 5.3 ) Injection Site Infections : Serious injection site infections, including abscess, cellulitis, necrosis, and ulcer have been reported. Instruct patients to contact their healthcare provider if signs or symptoms of an

Palynziq Black Box Warning

No black box warning on record for Palynziq

Other warnings & precautions

Palynziq Black Box Warning

No black box warning on record for Palynziq

Other warnings & precautions